Xurocitam BVG Tablet contains Betahistine 16 mg, Piracetam 400 mg, Vinpocetine 5 mg, Ginkgo Biloba 60 mg, and Vitamin D3 400 IU, a comprehensive neuro-vascular formulation designed for advanced vertigo management, cognitive support, and cerebral circulation enhancement.
Betahistine improves inner ear microcirculation and vestibular function, helping in reducing vertigo episodes, dizziness, and balance disturbances. Piracetam enhances neuronal metabolism and neurotransmission, while Vinpocetine improves cerebral blood flow and oxygen utilization. Ginkgo Biloba provides antioxidant and vasoregulatory support, and Vitamin D3 contributes to neuromuscular function and overall neurological health.
Clinically, this combination is beneficial in Ménière’s disease, chronic vertigo, vestibular dysfunction, cerebral insufficiency, memory impairment, and neuro-circulatory weakness. The tablet formulation ensures accurate dosing, consistent efficacy, and good patient compliance.
Xurocitam BVG Tablet strengthens the vertigo and neuro care therapy segment, widely used in ENT clinics, neurology practice, and general medicine, offering reliable symptom control, improved quality of life, and strong prescriber confidence.